Takayasu arteritis: advanced understanding is leading to new horizons

E Tombetti, JC Mason - Rheumatology, 2019 - academic.oup.com
Although outcomes in Takayasu arteritis (TAK) are improving, diagnosis is typically delayed
and significant arterial injury accrues. While wider use of non-invasive imaging is impacting …

Myocarditis in systemic immune-mediated diseases: Prevalence, characteristics and prognosis. A systematic review

CY Cheng, A Baritussio, AS Giordani, S Iliceto… - Autoimmunity …, 2022 - Elsevier
Many systemic immune-mediated diseases (SIDs) may involve the heart and present as
myocarditis with different histopathological pictures, ie lymphocytic, eosinophilic …

Therapeutic strategies for virus-negative myocarditis: a comprehensive review

G De Luca, C Campochiaro, S Sartorelli… - European journal of …, 2020 - Elsevier
Virus-negative or autoimmune myocarditis (VNM) is an inflammatory disease affecting the
myocardium that may occur as a distinct disease with exclusive cardiac involvement, or in …

Cardiovascular manifestations of systemic vasculitides

LH Silveira - Current rheumatology reports, 2020 - Springer
Abstract Purpose of Review Vasculitis can cause heart disease and are associated with
premature atherosclerosis, causing increased morbidity and mortality. Consequently, it is …

Tocilizumab for the treatment of giant cell arteritis

M Schirmer, F Muratore, C Salvarani - Expert Review of Clinical …, 2018 - Taylor & Francis
Introduction: Giant cell arteritis (GCA) is the most frequent type of vasculitis, occurring in
people older than 50 years. So far, treatment has been limited to corticosteroids and …

Genetic basis of myocarditis: myth or reality?

E Arbustini, N Narula, L Giuliani, A Di Toro - … : pathogenesis, diagnosis and …, 2020 - Springer
The genetic basis of myocarditis remains an intriguing concept, at least as long as the
definition of myocarditis constitutes the definitive presence of myocardial inflammation …

Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future …

SI Mavrogeni, PP Sfikakis, T Dimitroulas… - Rheumatology …, 2018 - Springer
Life expectancy in autoimmune rheumatic diseases (ARDs) remains lower compared to the
general population, due to various comoborbidities. Cardiovascular disease (CVD) …

Myocardial involvement in rheumatic disorders

G Markousis-Mavrogenis, A Pepe, L Gargani… - Current Heart Failure …, 2020 - Springer
Abstract Purpose of Review Autoimmune rheumatic diseases (ARDs) affect 8% of the
population and approximately 78% of patients are women. Myocardial disease in ARDs is …

Cardiovascular magnetic resonance in the diagnosis and management of cardiac and vascular involvement in the systemic vasculitides

SI Mavrogeni, T Dimitroulas… - Current Opinion in …, 2019 - journals.lww.com
CMR due to its great versatility gives valuable information about cardiac function, perfusion,
type of fibrosis and vascular integrity that may significantly contribute to treatment decisions …

Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis

A Giollo, RB Dumitru, PP Swoboda, S Plein… - … International Journal of …, 2021 - Springer
The prevalence of undiagnosed cardiac involvement in granulomatosis with polyangiitis
(GPA) is unknown. In this prospective study we investigated the utility of cardiovascular …